 | • レポートコード：D005-00490 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、院内感染管理の世界市場を広く調査・分析し、今後の市場展望をまとめております。院内感染管理の種類別市場規模（尿路感染症、血流感染症、手術部位感染症、院内感染肺炎、胃腸感染症、結核）、用途別市場規模（空気、水、物理的表面、皮膚消毒剤、滅菌）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Kimberly-Clark、Johnson & Johnson、Roche、BD、Merck、Cepheid、Bayer、Abott、Nordion ・地域別グローバル市場分析 2015年-2020年 ・院内感染管理の北米市場（アメリカ、カナダ、メキシコ） ・院内感染管理のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・院内感染管理のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・院内感染管理の南米市場（ブラジル、アルゼンチン） ・院内感染管理の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：尿路感染症、血流感染症、手術部位感染症、院内感染肺炎、胃腸感染症、結核 ・用途別分析：空気、水、物理的表面、皮膚消毒剤、滅菌 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Hospital Acquired Infection Control market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1179.1 million by 2025, from USD 1068.4 million in 2019.
The Hospital Acquired Infection Control market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Hospital Acquired Infection Control market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hospital Acquired Infection Control market has been segmented into:
Urinary Tract Infections
Blood Stream Infections
Surgical Site Infections
Hospital Acquired Pneumonia
Gastrointestinal Infections
Tuberculosis
By Application, Hospital Acquired Infection Control has been segmented into:
Air
Water
Physical Surfaces
Skin disinfectants
Sterilization
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hospital Acquired Infection Control market presented in the report. This section sheds light on the sales growth of different regional and country-level Hospital Acquired Infection Control markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hospital Acquired Infection Control market.
The report offers in-depth assessment of the growth and other aspects of the Hospital Acquired Infection Control market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Hospital Acquired Infection Control Market Share Analysis
Hospital Acquired Infection Control competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hospital Acquired Infection Control sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hospital Acquired Infection Control sales, revenue and market share for each player covered in this report.
The major players covered in Hospital Acquired Infection Control are:
Pfizer
Kimberly-Clark
Johnson & Johnson
Roche
BD
Merck
Cepheid
Bayer
Abott
Nordion
Table of Contents
1 Hospital Acquired Infection Control Market Overview
1.1 Product Overview and Scope of Hospital Acquired Infection Control
1.2 Classification of Hospital Acquired Infection Control by Type
1.2.1 Global Hospital Acquired Infection Control Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hospital Acquired Infection Control Revenue Market Share by Type in 2019
1.2.3 Urinary Tract Infections
1.2.4 Blood Stream Infections
1.2.5 Surgical Site Infections
1.2.6 Hospital Acquired Pneumonia
1.2.7 Gastrointestinal Infections
1.2.8 Tuberculosis
1.3 Global Hospital Acquired Infection Control Market by Application
1.3.1 Overview: Global Hospital Acquired Infection Control Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Air
1.3.3 Water
1.3.4 Physical Surfaces
1.3.5 Skin disinfectants
1.3.6 Sterilization
1.4 Global Hospital Acquired Infection Control Market by Regions
1.4.1 Global Hospital Acquired Infection Control Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hospital Acquired Infection Control (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hospital Acquired Infection Control Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hospital Acquired Infection Control Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hospital Acquired Infection Control Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hospital Acquired Infection Control Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hospital Acquired Infection Control Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kimberly-Clark
2.2.1 Kimberly-Clark Details
2.2.2 Kimberly-Clark Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kimberly-Clark SWOT Analysis
2.2.4 Kimberly-Clark Product and Services
2.2.5 Kimberly-Clark Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BD SWOT Analysis
2.5.4 BD Product and Services
2.5.5 BD Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck SWOT Analysis
2.6.4 Merck Product and Services
2.6.5 Merck Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cepheid
2.7.1 Cepheid Details
2.7.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cepheid SWOT Analysis
2.7.4 Cepheid Product and Services
2.7.5 Cepheid Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abott
2.9.1 Abott Details
2.9.2 Abott Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abott SWOT Analysis
2.9.4 Abott Product and Services
2.9.5 Abott Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
2.10 Nordion
2.10.1 Nordion Details
2.10.2 Nordion Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Nordion SWOT Analysis
2.10.4 Nordion Product and Services
2.10.5 Nordion Hospital Acquired Infection Control Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hospital Acquired Infection Control Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hospital Acquired Infection Control Players Market Share
3.2.2 Top 10 Hospital Acquired Infection Control Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hospital Acquired Infection Control Revenue and Market Share by Regions
4.2 North America Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
4.3 Europe Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
4.5 South America Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
5 North America Hospital Acquired Infection Control Revenue by Countries
5.1 North America Hospital Acquired Infection Control Revenue by Countries (2015-2020)
5.2 USA Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
5.3 Canada Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
5.4 Mexico Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
6 Europe Hospital Acquired Infection Control Revenue by Countries
6.1 Europe Hospital Acquired Infection Control Revenue by Countries (2015-2020)
6.2 Germany Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
6.3 UK Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
6.4 France Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
6.5 Russia Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
6.6 Italy Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hospital Acquired Infection Control Revenue by Countries
7.1 Asia-Pacific Hospital Acquired Infection Control Revenue by Countries (2015-2020)
7.2 China Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
7.3 Japan Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
7.4 Korea Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
7.5 India Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
8 South America Hospital Acquired Infection Control Revenue by Countries
8.1 South America Hospital Acquired Infection Control Revenue by Countries (2015-2020)
8.2 Brazil Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
8.3 Argentina Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hospital Acquired Infection Control by Countries
9.1 Middle East & Africa Hospital Acquired Infection Control Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
9.3 UAE Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
9.4 Egypt Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
9.5 South Africa Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hospital Acquired Infection Control Revenue and Market Share by Type (2015-2020)
10.2 Global Hospital Acquired Infection Control Market Forecast by Type (2019-2024)
10.3 Urinary Tract Infections Revenue Growth Rate (2015-2025)
10.4 Blood Stream Infections Revenue Growth Rate (2015-2025)
10.5 Surgical Site Infections Revenue Growth Rate (2015-2025)
10.6 Hospital Acquired Pneumonia Revenue Growth Rate (2015-2025)
10.7 Gastrointestinal Infections Revenue Growth Rate (2015-2025)
10.8 Tuberculosis Revenue Growth Rate (2015-2025)
11 Global Hospital Acquired Infection Control Market Segment by Application
11.1 Global Hospital Acquired Infection Control Revenue Market Share by Application (2015-2020)
11.2 Hospital Acquired Infection Control Market Forecast by Application (2019-2024)
11.3 Air Revenue Growth (2015-2020)
11.4 Water Revenue Growth (2015-2020)
11.5 Physical Surfaces Revenue Growth (2015-2020)
11.6 Skin disinfectants Revenue Growth (2015-2020)
11.7 Sterilization Revenue Growth (2015-2020)
12 Global Hospital Acquired Infection Control Market Size Forecast (2021-2025)
12.1 Global Hospital Acquired Infection Control Market Size Forecast (2021-2025)
12.2 Global Hospital Acquired Infection Control Market Forecast by Regions (2021-2025)
12.3 North America Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
12.4 Europe Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
12.6 South America Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Hospital Acquired Infection Control Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hospital Acquired Infection Control by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hospital Acquired Infection Control Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hospital Acquired Infection Control Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Hospital Acquired Infection Control Major Business
Table 7. Pfizer Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Hospital Acquired Infection Control Product and Solutions
Table 10. Pfizer Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Kimberly-Clark Corporate Information, Location and Competitors
Table 12. Kimberly-Clark Hospital Acquired Infection Control Major Business
Table 13. Kimberly-Clark Hospital Acquired Infection Control Total Revenue (USD Million) (2018-2019)
Table 14. Kimberly-Clark SWOT Analysis
Table 15. Kimberly-Clark Hospital Acquired Infection Control Product and Solutions
Table 16. Kimberly-Clark Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Johnson & Johnson Corporate Information, Location and Competitors
Table 18. Johnson & Johnson Hospital Acquired Infection Control Major Business
Table 19. Johnson & Johnson Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 20. Johnson & Johnson SWOT Analysis
Table 21. Johnson & Johnson Hospital Acquired Infection Control Product and Solutions
Table 22. Johnson & Johnson Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Hospital Acquired Infection Control Major Business
Table 25. Roche Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Hospital Acquired Infection Control Product and Solutions
Table 28. Roche Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. BD Corporate Information, Location and Competitors
Table 30. BD Hospital Acquired Infection Control Major Business
Table 31. BD Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 32. BD SWOT Analysis
Table 33. BD Hospital Acquired Infection Control Product and Solutions
Table 34. BD Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Corporate Information, Location and Competitors
Table 36. Merck Hospital Acquired Infection Control Major Business
Table 37. Merck Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 38. Merck SWOT Analysis
Table 39. Merck Hospital Acquired Infection Control Product and Solutions
Table 40. Merck Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cepheid Corporate Information, Location and Competitors
Table 42. Cepheid Hospital Acquired Infection Control Major Business
Table 43. Cepheid Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 44. Cepheid SWOT Analysis
Table 45. Cepheid Hospital Acquired Infection Control Product and Solutions
Table 46. Cepheid Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bayer Corporate Information, Location and Competitors
Table 48. Bayer Hospital Acquired Infection Control Major Business
Table 49. Bayer Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 50. Bayer SWOT Analysis
Table 51. Bayer Hospital Acquired Infection Control Product and Solutions
Table 52. Bayer Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abott Corporate Information, Location and Competitors
Table 54. Abott Hospital Acquired Infection Control Major Business
Table 55. Abott Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 56. Abott SWOT Analysis
Table 57. Abott Hospital Acquired Infection Control Product and Solutions
Table 58. Abott Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Nordion Corporate Information, Location and Competitors
Table 60. Nordion Hospital Acquired Infection Control Major Business
Table 61. Nordion Hospital Acquired Infection Control Total Revenue (USD Million) (2017-2018)
Table 62. Nordion SWOT Analysis
Table 63. Nordion Hospital Acquired Infection Control Product and Solutions
Table 64. Nordion Hospital Acquired Infection Control Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Hospital Acquired Infection Control Revenue (Million USD) by Players (2015-2020)
Table 66. Global Hospital Acquired Infection Control Revenue Share by Players (2015-2020)
Table 67. Global Hospital Acquired Infection Control Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Hospital Acquired Infection Control Revenue Market Share by Regions (2015-2020)
Table 69. North America Hospital Acquired Infection Control Revenue by Countries (2015-2020)
Table 70. North America Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Table 71. Europe Hospital Acquired Infection Control Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Hospital Acquired Infection Control Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Hospital Acquired Infection Control Revenue by Countries (2015-2020)
Table 74. South America Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Hospital Acquired Infection Control Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Table 77. Global Hospital Acquired Infection Control Revenue (Million USD) by Type (2015-2020)
Table 78. Global Hospital Acquired Infection Control Revenue Share by Type (2015-2020)
Table 79. Global Hospital Acquired Infection Control Revenue Forecast by Type (2021-2025)
Table 80. Global Hospital Acquired Infection Control Revenue by Application (2015-2020)
Table 81. Global Hospital Acquired Infection Control Revenue Share by Application (2015-2020)
Table 82. Global Hospital Acquired Infection Control Revenue Forecast by Application (2021-2025)
Table 83. Global Hospital Acquired Infection Control Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hospital Acquired Infection Control Picture
Figure 2. Global Hospital Acquired Infection Control Revenue Market Share by Type in 2019
Figure 3. Urinary Tract Infections Picture
Figure 4. Blood Stream Infections Picture
Figure 5. Surgical Site Infections Picture
Figure 6. Hospital Acquired Pneumonia Picture
Figure 7. Gastrointestinal Infections Picture
Figure 8. Tuberculosis Picture
Figure 9. Hospital Acquired Infection Control Revenue Market Share by Application in 2019
Figure 10. Air Picture
Figure 11. Water Picture
Figure 12. Physical Surfaces Picture
Figure 13. Skin disinfectants Picture
Figure 14. Sterilization Picture
Figure 15. Global Hospital Acquired Infection Control Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Hospital Acquired Infection Control Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Hospital Acquired Infection Control Revenue Market Share in 2019
Figure 24. Global Top 10 Players Hospital Acquired Infection Control Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Hospital Acquired Infection Control Revenue Market Share by Regions (2015-2020)
Figure 28. Global Hospital Acquired Infection Control Revenue Market Share by Regions in 2018
Figure 29. North America Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 30. Europe Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 32. South America Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 34. North America Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Figure 35. North America Hospital Acquired Infection Control Revenue Market Share by Countries in 2019
Figure 36. USA Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 37. Canada Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 39. Europe Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Hospital Acquired Infection Control Revenue Market Share by Countries in 2019
Figure 41. Germany Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 42. UK Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 43. France Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 44. Russia Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 45. Italy Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Hospital Acquired Infection Control Revenue Market Share by Countries in 2019
Figure 48. China Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 49. Japan Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 50. Korea Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 51. India Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 53. South America Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Figure 54. South America Hospital Acquired Infection Control Revenue Market Share by Countries in 2019
Figure 55. Brazil Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Hospital Acquired Infection Control Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Hospital Acquired Infection Control Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 60. UAE Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Hospital Acquired Infection Control Revenue and Growth Rate (2015-2020)
Figure 63. Global Hospital Acquired Infection Control Revenue Share by Type (2015-2020)
Figure 64. Global Hospital Acquired Infection Control Revenue Share by Type in 2019
Figure 65. Global Hospital Acquired Infection Control Market Share Forecast by Type (2021-2025)
Figure 66. Global Urinary Tract Infections Revenue Growth Rate (2015-2020)
Figure 67. Global Blood Stream Infections Revenue Growth Rate (2015-2020)
Figure 68. Global Surgical Site Infections Revenue Growth Rate (2015-2020)
Figure 69. Global Hospital Acquired Pneumonia Revenue Growth Rate (2015-2020)
Figure 70. Global Gastrointestinal Infections Revenue Growth Rate (2015-2020)
Figure 71. Global Tuberculosis Revenue Growth Rate (2015-2020)
Figure 72. Global Hospital Acquired Infection Control Revenue Share by Application (2015-2020)
Figure 73. Global Hospital Acquired Infection Control Revenue Share by Application in 2019
Figure 74. Global Hospital Acquired Infection Control Market Share Forecast by Application (2021-2025)
Figure 75. Global Air Revenue Growth Rate (2015-2020)
Figure 76. Global Water Revenue Growth Rate (2015-2020)
Figure 77. Global Physical Surfaces Revenue Growth Rate (2015-2020)
Figure 78. Global Skin disinfectants Revenue Growth Rate (2015-2020)
Figure 79. Global Sterilization Revenue Growth Rate (2015-2020)
Figure 80. Global Hospital Acquired Infection Control Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Hospital Acquired Infection Control Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Hospital Acquired Infection Control Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
Figure 84. Europe Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
Figure 86. South America Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Hospital Acquired Infection Control Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
市中肺炎（CAP）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Community Acquired Pneumonia (CAP) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Community …- 下気道感染症治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Lower Respiratory Tract Infection Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The L…
- 感染予防および経腸アクセスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Infection Prevention and Enteral Access market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Infec…
- 耳感染症治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Ear Infection Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 18100 million by 2025, from USD 14830 million in 2019. The Ear Infection …
- 全身感染治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Systemic Infection Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Systemic Infecti…